CHU La Timone
Département de Pharmacologie Clinique
Pr Olivier BLIN
Directeur du Centre de Pharmacologie Clinique et de Pharmacovigilance
Chargée de mission :
DHU for care, research and university-hospital teaching
N for neurodegenerative diseases and aging
E for Euro-Méditerranée
DHUNE is part of the French National Plan 2014-2019 against Neurodegenerative Diseases in which several of its members actively participate
The DHUNE centre is part of 7 French centres that have been labelled as excellence centre by AVIESAN (National Alliance for Life Sciences and Health) within the network of Centres of Excellence in Neurodegeneration (CoEN) in Europe and Canada.
Furthermore, DHUNE is labelled as FHU (University Hospital Federation).
This label is part of the 2014-2019 plan on neurodegenerative diseases (Alzheimer's, Parkinson's, ALS, multiple sclerosis...). It enables DHUNE to participate in the call for projects from the RHU (Hospital University Research in Health) from the National Research Agency (ANR) and thereby benefit from financial support of a value between 5 and 10 million euros for 5 years of research.